Sapphire Medical Clinics has today launched a service to help patients better understand the legality and eligibility of cannabis medicine.
The new service falls within the CPD-certified Sapphire Institute of Medical Cannabis Education which launched in 2020 with a focus on healthcare professional training.
Patients and carers of those with chronic conditions such as pain and anxiety can now access to a range of educational resources, including Q&A videos and also have the opportunity to ask questions.
The launch of the new service was welcomed by PLEA Advocacy Director, Lucy Stafford.
Stafford, who is herself a medical cannabis patient, said:
“We welcome this new initiative and The Sapphire Institute’s free education centre for patients.
“Medical cannabis can be considered for a range of conditions, but patients need accurate and up to date information on treatment.
“PLEA’s patient working group is delighted to have provided feedback on the content and development of this Patient Education Centre.”
Laura is a 30-year-old Sapphire patient who lives with persistent Endometriosis pain.
The Endo Monologues blog author commented:
“I think it’s absolutely fantastic! I love the in-depth videos and the ability to download the guide to browse in your own time, it’s definitely something I would recommend to my followers if they were new to the process.”
In May, the first 129 patient outcomes recorded by the UK Medical Cannabis Registry showed ‘significant improvements’ to anxiety, pain and sleep scores.
The Registry, which now includes more than 2,000 patients, was set up by doctors at Sapphire Medical Clinics but includes real-world data from patients across the UK.